Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy

This publication has 10 references indexed in Scilit:

• Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies
  Radiotherapy and Oncology, 2001
• Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Clinical and dosimetric predictors of radiation-induced esophageal toxicity
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide
  New England Journal of Medicine, 1999
• Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small-cell carcinoma of the lung
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study.
  Journal of Clinical Oncology, 1996
• Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
  Journal of Clinical Oncology, 1995
• Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1990